Nathalie Auber
@Sofinnova Investments, Inc.
Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.
Assets under management
The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
QQQInvesco Qqq Tr
| 0% | $191.644M↓ Put 400,000 shares@ $479.11 avg price | Exited |
ASNDAscendis Pharma A S
| 0% | $100.142M 734,284 shares@ $136.39 avg price | Exited |
SYKStryker Corporation
| 0% | $65.697M 193,084 shares@ $340.25 avg price | Exited |
ISRGIntuitive Surgical Inc
| 0% | $61.041M 137,217 shares@ $444.85 avg price | Exited |
ALGNAlign Technology Inc
| 0% | $52.758M 218,524 shares@ $241.43 avg price | Exited |
ALNYAlnylam Pharmaceuticals Inc
| 0% | $48.097M 197,929 shares@ $243.0 avg price | Exited |
ABTAbbott Labs
| 0% | $40.546M↑ Call 390,200 shares@ $103.91 avg price | Exited |
IDXXIdexx Labs Inc
| 0% | $31.114M 63,862 shares@ $487.2 avg price | Exited |
SRPTSarepta Therapeutics Inc
| 0% | $30.945M 195,852 shares@ $158.0 avg price | Exited |
XBISpdr Ser Tr
| 0% | $23.178M↓ Put 250,000 shares@ $92.71 avg price | Exited |